Conference abstract · 21 Mar 2019
Conference abstractPublished 7 Dec 2015
Replication Competent Viral Vectors for Vaccine Development
GeoVax, Inc, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Viral infections account for 15 million deaths per year, one-third of all mortalities worldwide. The most effective medical approach to combat viral diseases and reduce deaths is vaccinations, which have less adverse side effects than drugs while inducing longer lasting protection from reinfection. Live attenuated, inactivated, or subunit vaccine approaches have been successfully utilized to combat mortalities caused by infectious diseases such as yellow fever, varicella, measles, mumps, rubella, influenza, smallpox, polio, rabies, hepatitis A and B, and human papillomavirus. Viruses themselves have also been used as vectors (either replication competent or replication deficient) for development of vaccines against both infectious and non-infectious diseases. The most important factor in the construction of effective viral vectors is finding the right balance between safety and immunogenicity. Although live viral vaccine vectors are highly efficacious, there is also a greater potential risk involved with their broader usage because they are replication-competent. Vaccines based on replication-incompetent viruses are perceived to be safer but there is not yet any vaccine on the market for human use. In this talk, characteristics of both replication-deficient and replication-competent viral vectors and barriers for their developments will be discussed. The talk will specifically focus on a few vector examples that have either generated marketed products or have successfully completed their phase 3 efficacy trials.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Dec 2015
Engineering of Highly Efficient Recombinant Viral Vectors for Development of Prime-Boost Vaccines Against Viral Diseases
Short communication · 4 Aug 2021
Production and characterization of viral vectors for vaccine development
Short communication · 2015
Immunization by Replication-Competent, Controlled Viral Pathogen – A Novel Approach Worth Exploring for Diseases Refractory to Effective Conventional Vaccination?
Conference abstract · 27 Jul 2015
Unique IL-4R antagonist and IL-13Ra2 adjuvanted pox viral vector-based HIV vaccines
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectInfectious Diseases
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Farshad Guirakhoo”
